Advertisement
This Article is From Jun 21, 2018

Atal Bihari Vajpayee Showing Signs Of Improvement: Officials

The 93-year-old leader was admitted to the premier hospital on June 11 with a kidney tract infection and chest congestion.

Atal Bihari Vajpayee Showing Signs Of Improvement: Officials
Atal Bihari Vajpayee is the only non-Congress prime minister to complete the full term of five years
New Delhi: Former Prime Minister Atal Bihari Vajpayee's condition is improving and he is likely to be discharged soon, sources at the All India Institutes of Medical Sciences (AIIMS) said today.

The BJP stalwart is admitted to the ICU of the cardio-thoracic centre at the hospital and has shown improvements in the last 10 days.

"He continues to show improvement and is being monitored by a team of doctors," an AIIMS official said.

The 93-year-old leader was admitted to the premier hospital on June 11 with a kidney tract infection, chest congestion and urine output on the lower side.
 
aiims

The former prime minister continues to remain in the ICU of the cardio-thoracic centre at AIIMS

He was immediately evaluated by a team of doctors and put on injectable antibiotics.

Mr Vajpayee, a diabetic, has one functional kidney. He suffered a stroke in 2009 which weakened his cognitive abilities. Subsequently, he developed dementia.

Prime Minister Narendra Modi, BJP chief Amit Shah, RSS chief Mohan Bhagwat, former prime ministers Manmohan Singh and HD Deve Gowda, Congress president Rahul Gandhi, Vice President Vankaiah Naidu and several chief ministers and union ministers have visited Mr Vajpayee at the AIIMS over the past 11 days.

Atal Bihari Vajpayee was thrice elected as the prime minister between 1996 and 1999 and is the only non-Congress prime minister to complete the full term of five years, from 1999 to 2004. As his health deteriorated, he slowly withdrew himself from public life and remained confined to his residence for years. 
 

Track Latest News Live on NDTV.com and get news updates from India and around the world

Follow us: